Skip to content
MEO NextGenDeveloper StudioDEV
  1. Dashboard
  2. Questions
  3. SBA
  4. Q154
SBA

SBA — Single Best Answer · Review

Question 154

Delivery suite → Haemorrhage

NextGen Workflow Status Needs Review
SQL status generated
Destination Site
Type SSBA
UUID adf60d49-3480-446b-b814-83368a1c3b62

Classification

Speciality
Obstetrics and Gynaecology
Group
Clinical
Title
Delivery suite
Topic
Haemorrhage
Subtopic 1
Antepartum haemorrhage
Subtopic 2
Major haemorrhage
Subtopic 3
Investigation
Question Type
SBA

Question

SSBA
Question Header
A woman with a major placental abruption is receiving active resuscitation for continuing blood loss. Her initial coagulation screen was normal, but haemorrhage has continued substantially during the subsequent 40 minutes. Which approach to laboratory assessment is most appropriate?
Question Stem
—

Options

A The normal initial coagulation screen excludes clinically important coagulopathy for the remainder of the haemorrhage
B Repeat testing is unnecessary unless the platelet count falls below 50 × 10⁹/L
C Coagulation studies should next be repeated routinely after 24 hours
D Serial reassessment of haemoglobin, platelets and coagulation is required because the haemostatic state can change rapidly during continuing major haemorrhage
E Laboratory monitoring should stop once blood-component therapy begins because transfusion invalidates subsequent results

Explanation

Major obstetric haemorrhage is dynamic. Continuing blood loss, consumption of coagulation factors and subsequent fluid and blood-component replacement can rapidly change haemoglobin, platelet count and coagulation status. This is particularly important in placental abruption, where consumptive coagulopathy may evolve quickly. A reassuring initial coagulation screen therefore cannot be assumed to remain valid during continuing haemorrhage. Laboratory assessment must be repeated according to the clinical course while resuscitation and definitive obstetric management continue.

Option Validity

A) Coagulopathy may evolve rapidly after an initially normal result, particularly during continuing placental abruption and major blood loss.

B) Repeat assessment should be driven by the ongoing clinical haemorrhage rather than by a single platelet threshold.

C) Deferring repeat coagulation assessment for 24 hours is inappropriate during active major obstetric haemorrhage.

E) Blood-component therapy does not remove the need for subsequent laboratory monitoring; repeat results help guide further replacement.

Further Reading

RCOG Green-top Guideline No. 63. Antepartum Haemorrhage. Royal College of Obstetricians and Gynaecologists; 2011.

Source & metrics

Authored Difficulty
4.00
Evaluation Score
—
Destination
Site
Source
—
Source Section
—
Source Locator
—
Updated
2026-10-06 01:57:35
Difficulty Factor
Not available yet
Attended Users
No candidate-attempt data yet
Review Question